Literature DB >> 7811866

Mechanisms of brain injury in bacterial meningitis: workshop summary.

H W Pfister1, A Fontana, M G Täuber, A Tomasz, W M Scheld.   

Abstract

Morbidity and mortality associated with bacterial meningitis remain high, although antibiotic therapy has improved during recent decades. The major intracranial complications of bacterial meningitis are cerebrovascular arterial and venous involvement, brain edema, and hydrocephalus with a subsequent increase of intracranial pressure. Experiments in animal models and cell culture systems have focused on the pathogenesis and pathophysiology of bacterial meningitis in an attempt to identify the bacterial and/or host factors responsible for brain injury during the course of infection. An international workshop entitled "Bacterial Meningitis: Mechanisms of Brain Injury" was organized by the Department of Neurology at the University of Munich and was held in Eibsee, Germany, in June 1993. This conference provided a forum for the exchange of current information on bacterial meningitis, including data on the clinical spectrum of complications, the associated morphological alterations, the role of soluble inflammatory mediators (in particular cytokines) and of leukocyte-endothelial cell interactions in tissue injury, and the molecular mechanisms of neuronal injury, with potential mediators such as reactive oxygen species, reactive nitrogen species, and excitatory amino acids. It is hoped that a better understanding of the pathophysiological events that take place during bacterial meningitis will lead to the development of new therapeutic regimens.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7811866     DOI: 10.1093/clinids/19.3.463

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  17 in total

1.  Effects of polysaccharide fucoidin on cerebrospinal fluid interleukin-1 and tumor necrosis factor alpha in pneumococcal meningitis in the rabbit.

Authors:  C Granert; J Raud; A Waage; L Lindquist
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Bacterial Meningitis.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-05       Impact factor: 3.598

Review 3.  Reprogramming the host response in bacterial meningitis: how best to improve outcome?

Authors:  M van der Flier; S P M Geelen; J L L Kimpen; I M Hoepelman; E I Tuomanen
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

4.  Evidence for intrathecal synthesis of alternative pathway complement activation proteins in experimental meningitis.

Authors:  P F Stahel; K Frei; A Fontana; H P Eugster; B H Ault; S R Barnum
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

5.  Cell wall-mediated neuronal damage in early sepsis.

Authors:  Carlos J Orihuela; Sophie Fillon; S Hope Smith-Sielicki; Karim C El Kasmi; Geli Gao; Konstantinos Soulis; Avinash Patil; Peter J Murray; Elaine I Tuomanen
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 6.  Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy.

Authors:  A M van Furth; J J Roord; R van Furth
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

7.  Pneumolysin is the main inducer of cytotoxicity to brain microvascular endothelial cells caused by Streptococcus pneumoniae.

Authors:  G Zysk; B K Schneider-Wald; J H Hwang; L Bejo; K S Kim; T J Mitchell; R Hakenbeck; H P Heinz
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

8.  The polysaccharide fucoidin inhibits the antibiotic-induced inflammatory cascade in experimental pneumococcal meningitis.

Authors:  C Granert; J Raud; L Lindquist
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

9.  Chemokine profiles in the cerebrospinal fluid (CSF) during the course of pyogenic and tuberculous meningitis.

Authors:  C M Mastroianni; L Lancella; F Mengoni; M Lichtner; P Santopadre; C D'Agostino; F Ticca; V Vullo
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

10.  Tumor necrosis factor alpha upregulates human microglial cell production of interleukin-10 in vitro.

Authors:  W S Sheng; S Hu; F H Kravitz; P K Peterson; C C Chao
Journal:  Clin Diagn Lab Immunol       Date:  1995-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.